Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 14, 2018 - Issue
Submit an article Journal homepage
72
Views
10
CrossRef citations to date
0
Altmetric
Review

Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis

Yu-Tuan Wu1 Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China, [email protected]
,
Zhou Xu1 Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China, [email protected]
,
Ke Zhang2 Department of Orthopedics, Children’s Hospital of Chongqing Medical University, Chongqing 400020, China
,
Jiu-song Wu3 Department of General Surgery, Children’s Hospital of Chongqing Medical University, Chongqing 400020, China
,
Xin Li1 Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China, [email protected]
,
Bilal Arshad1 Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China, [email protected]
,
Ying-Cun Li3 Department of General Surgery, Children’s Hospital of Chongqing Medical University, Chongqing 400020, China
,
Zhong-Liang Wang2 Department of Orthopedics, Children’s Hospital of Chongqing Medical University, Chongqing 400020, China
,
Hong-Yuan Li1 Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China, [email protected]
,
Kai-Nan Wu1 Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China, [email protected]
&
Ling-Quan Kong1 Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China, [email protected]Correspondence[email protected]
 show all
Pages 1789-1797 | Published online: 26 Sep 2018

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Tie Lin, Jing Yang, Xuan Hong, ZhaoYang Yang, Ting Ge & Meng Wang. (2020) Nutritional status in patients with advanced lung cancer undergoing chemotherapy: a prospective observational study. Nutrition and Cancer 72:7, pages 1225-1230.
Read now

Articles from other publishers (9)

Juan Carlos Vazquez, Silvia Antolin, Manuel Ruiz-Borrego, Sonia Servitja, Emilio Alba, Agusti Barnadas, Ana Lluch, Miguel Martin, Alvaro Rodriguez-Lescure, Ivan Sola, Xavier Bonfill, Gerard Urrutia & Pedro Sanchez-Rovira. (2022) Dual neoadjuvant blockade plus chemotherapy versus monotherapy for the treatment of women with non-metastatic HER2-positive breast cancer: a systematic review and meta-analysis. Clinical and Translational Oncology 25:4, pages 941-958.
Crossref
Zhenkun Fu, Zhoujun Lin, Mao Yang & Chenggang Li. (2022) Cardiac Toxicity From Adjuvant Targeting Treatment for Breast Cancer Post-Surgery. Frontiers in Oncology 12.
Crossref
Silvia Falcon, Luis Riva, Christina Flores, Delphis Vera, Joseph Pinto & Henry Gomez. (2022) Neoadjuvant pertuzumab in non‑metastatic HER2‑positive breast tumors: Multicentric study in Peru (NeoHer). Molecular and Clinical Oncology 16:3.
Crossref
Nurgul K. Bakirhan & Cigdem Yucel. 2022. Nanomaterials for Cancer Detection Using Imaging Techniques and Their Clinical Applications. Nanomaterials for Cancer Detection Using Imaging Techniques and Their Clinical Applications 303 330 .
Jie Zhang, Yushuai Yu, Yuxiang Lin, Shaohong Kang, Xinyin Lv, Yushan Liu, Jielong Lin, Jun Wang & Chuangui Song. (2021) Efficacy and safety of neoadjuvant therapy for HER2-positive early breast cancer: a network meta-analysis. Therapeutic Advances in Medical Oncology 13, pages 175883592110069.
Crossref
Andrea Rocca, Pietro Cortesi, Laura Cortesi, Lorenzo Gianni, Federica Matteucci, Lorenzo Fantini, Antonio Maestri, Donata Casadei Giunchi, Luigi Cavanna, Rosa Ciani, Fabio Falcini, Antonella Bagni, Elena Meldoli, Monia Dall’Agata, Roberta Volpi, Daniele Andreis, Oriana Nanni, Annalisa Curcio, Leonardo Lucchi, Dino Amadori & Anna Fedeli. (2021) Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer. Therapeutic Advances in Medical Oncology 13, pages 175883592098563.
Crossref
Hua Wei, Yong-Jun Zhang, Ting Yu, Xiao-Yan Yan & Qian Jiang. (2021) Methodological quality evaluation of systematic reviews or meta-analysis of trastuzumab-based therapy for breast cancer. Medicine 100:4, pages e24389.
Crossref
Nadia Harbeck. (2019) Emerging strategies in neoadjuvant treatment of patients with HER2-positive early breast cancer. The Breast 48, pages S97-S102.
Crossref
Lucian Pop, Ioan Dumitru Suciu, Olivia Ionescu, Paris Ionescu & Oana Daniela Toader. (2019) The Dual Blockade in the Neoadjuvant Setting of HER-2 Positive Early-Stage Breast Cancer. Journal of Medicine and Life 12:4, pages 329-331.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.